Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for oral Icalcaprant in adults with Major Depressive Disorder, assessing change in disease activity and adverse events; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Icalcaprant (icalcaprant)

Snippet

Sponsor: AbbVie | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING